NCT02157831 · Interventional trial
Redosing With CP-870, 893 in Patients With Clinical Benefit After a Single Infusion From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors
Overall registry status Completed
Early Phase 1
Conditions Solid Tumors
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory